Identifying the vulnerable patient with rupture-prone plaque.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal of Cardiology

• Publication date

  2008-06-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.amjcard.2008.04.013PMID 18549869
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2008cited by this paper
• Pathology of the vulnerable plaque.

  2007cited by this paper
• Optimal medical therapy with or without PCI for stable coronary disease.

  2007cited by this paper
• Elevated Lp-PLA2 Levels Add Prognostic Information to the Metabolic Syndrome on Incidence of Cardiovascular Events Among Middle-Aged Nondiabetic Subjects

  2007cited by this paper
• Brachial Flow-Mediated Dilation Predicts Incident Cardiovascular Events in Older Adults: The Cardiovascular Health Study

  2007cited by this paper
• Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2007cited by this paper
• Endurance Exercise TVaining Reduces Lp-PLA2 in Young White Adults: The HERITAGE Family Study

  2007cited by this paper
• Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target

  2007cited by this paper
• Abstract 258: Oxidized LDL-Induced Upregulation of IL-18 in Monocytes/Macrophages is Modulated by Lipoprotein-Associated Phospholipase A2 Potential Mechanism of Inflammatory Burden in Atherosclerosis

  2006cited by this paper
• From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.

  2006cited by this paper
• From Vulnerable Plaque to Vulnerable Patient—Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report

  2006cited by this paper
• Lipoprotein-Associated Phospholipase A2 Protein Expression in the Natural Progression of Human Coronary Atherosclerosis

  2006cited by this paper
• Pathology of the Vulnerable Plaque

  2006cited by this paper
• Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.

  2006cited by this paper
• Effects of extended-release niacin on lipoprotein particle size, distribution, and inflammatory markers in patients with coronary artery disease.

  2006cited by this paper
• Pathophysiology of Coronary Artery Disease

  2005cited by this paper
• In Vivo Characterization of Coronary Atherosclerotic Plaque by Use of Optical Coherence Tomography

  2005cited by this paper
• Restenosis: another "dysfunction" of the endothelium.

  2005cited by this paper
• Cancer Facts & Figures 2004

  2004cited by this paper
• Obesity-induced inflammatory changes in adipose tissue.

  2003cited by this paper
• Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform?

  2003cited by this paper
• Prevalence of conventional risk factors in patients with coronary heart disease.

  2003cited by this paper
• From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

  2003cited by this paper
• Coronary Endothelial Dysfunction Is Associated With an Increased Risk of Cerebrovascular Events

  2003cited by this paper
• Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy.

  2003cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults: Evidence From Intravascular Ultrasound

  2001cited by this paper
• Coronary plaque disruption.

  1995cited by this paper
• Prognosis After the Onset of Coronary Heart Disease An Investigation of Differences in Outcome Between the Sexes According to Initial Coronary Disease Presentation

  1993cited by this paper
• Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease.

  1992cited by this paper
• Compensatory enlargement of human atherosclerotic coronary arteries.

  1987cited by this paper

• High Tyrosol and Hydroxytyrosol Intake Reduces Arterial Inflammation and Atherosclerotic Lesion Microcalcification in Healthy Older Populations

  2024cites this paper
• Association of Lipoprotein-associated phospholipase A2 With Carotid Intima-Media Thickness in Acute Cerebral Infarction Patients

  2024cites this paper
• Anti-Inflammatory Drugs in Patients with Ischemic Heart Disease

  2021cites this paper
• Expert Consensus on Some Issues of Cerebral and Carotid Vascular Ultrasonography

  2021cites this paper
• Body Mass Index and Major Adverse Cardiovascular Events: A Secondary Analysis Based on a Retrospective Cohort Study

  2020cites this paper
• The significance of Agaricus blazei as an immunomodulator of the level of IL-17 in Balb/C mice with atherosclerosis

  2020cites this paper
• On the present and future role of Lp-PLA2 in atherosclerosis-related cardiovascular risk prediction and management

  2020cites this paper
• Inflammatory Biomarkers for Cardiovascular Risk Stratification in Familial Hypercholesterolemia.

  2020cites this paper
• Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.

  2018cites this paper
• Impact of motion compensation and partial volume correction for 18F-NaF PET/CT imaging of coronary plaque

  2017cites this paper
• Partial volume correction for improved PET quantification in 18F-NaF imaging of atherosclerotic plaques

  2017cites this paper
• Differential associations of systolic and diastolic time rate of blood pressure variation with carotid atherosclerosis and plaque echogenicity

  2017cites this paper
• Lipoprotein-associated phospholipase A2 and risk of incident peripheral arterial disease in a multi-ethnic cohort: The Multi-Ethnic Study of Atherosclerosis

  2017cites this paper
• Impact of motion compensation and partial volume correction for 18F-NaF PET/CT imaging of coronary plaque.

  2017cites this paper
• Obesity and cardiovascular outcomes: a review

  2016cites this paper
• Detection of gold nanorods uptake by macrophages using scattering analyses combined with diffusion reflection measurements as a potential tool for in vivo atherosclerosis tracking

  2015cites this paper
• Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.

  2015cites this paper
• Proportion of lipids in relation to size or burden of the atherosclerotic plaque in human coronary arteries

  2015cites this paper
• "Observational Medicine" should be replaced by "Real Science".

  2015cites this paper
• Clinical Feasibility and Monitoring of the Effects of Anti-inflammatory Therapy in Atherosclerosis

  2015cites this paper
• A Comparative Study of Coronary Atherosclerosis in Young and Old

  2015cites this paper
• Effect of Pitavastatin on Vascular Reactivity in Hypercholesterolemic Rabbits

  2014cites this paper
• High-Sensitivity C-Reactive Protein as a Predictor of Cardiovascular Events after ST-Elevation Myocardial Infarction

  2014cites this paper
• Targeting P-Selectin by Gallium-68–Labeled Fucoidan Positron Emission Tomography for Noninvasive Characterization of Vulnerable Plaques: Correlation With In Vivo 17.6T MRI

  2014cites this paper
• Cellular and Biochemical Effects of Sparstolonin B on Endothelial Cells to Inhibit Angiogenesis

  2014cites this paper
• Dysfunctional HDL-cholesterol: a potential link between high levels of HDL-cholesterol and cardiovascular disease?

  2013cites this paper
• Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.

  2013cites this paper
• Caractérisation de l'inflammation artérielle associée au vieillissement par la tomographie d'émission par positrons (TEP)

  2013cites this paper
• Cardiac PET-CT and CT Angiography

  2013cites this paper
• Monitoring anti-inflammatory therapies in patients with atherosclerosis: FDG PET emerges as the method of choice

  2012cites this paper
• Noninvasive vascular ultrasound elastography

  2012cites this paper
• Noninvasive estimation of the blood pressure waveform in the carotid artery using continuous finger blood pressure monitoring.

  2012cites this paper
• Estimating cyclic shear strain in the common carotid artery using radiofrequency ultrasound.

  2012cites this paper
• Serum tartrate-resistant acid phosphatase isoform 5a (TRACP5a) as a potential risk marker in cardiovascular disease.

  2011cites this paper
• Circulating microparticle levels in patients with coronary artery disease: a new indicator of vulnerability?

  2011cites this paper
• Simvastatin Reduces Lipoprotein-associated Phospholipase A2 in Lipopolysaccharide-stimulated Human Monocyte–derived Macrophages Through Inhibition of the Mevalonate–Geranylgeranyl Pyrophosphate–RhoA-p38 Mitogen-activated Protein Kinase Pathway

  2011cites this paper
• A Method Proves Its Mettle

  2011cites this paper
• The forgotten face of regular physical exercise: a 'natural' anti-atherogenic activity.

  2011cites this paper
• Omega-3 fatty acids and lipoprotein associated phospholipase A2 in healthy older adult males and females

  2011cites this paper
• PET imaging of aortic atherosclerosis: Is combined imaging of plaque anatomy and function an amaranthine quest or conceivable reality?

  2011cites this paper
• Intracranial Vessel Wall Imaging at 7.0-T MRI

  2011cites this paper
• Lipoprotein phospholipase A2 in patients with isolated coronary artery ectasia

  2011cites this paper
• Fluorescence lifetime imaging for the characterization of the biochemical composition of atherosclerotic plaques.

  2011cites this paper
• Shear) Strain Imaging Used in Noninvasive Detection of Vulnerable Plaques in the Carotid Arterial Wall

  2011cites this paper
• Vascular disease: obesity and excess weight as modulators of risk

  2011cites this paper
• Use of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography in Assessment of Cardiovascular Disease Risk and Atherosclerosis Progression

  2011cites this paper
• Absolute quantification of myocardial perfusion: a method proves its mettle.

  2011cites this paper
• Dual activity of serum lipoprotein-associated phospholipase A2 yielding positive and inverse associations with cardiometabolic risk

  2011cites this paper
• Estimation of Longitudinal Shear Strain in the Carotid Arterial Wall Using Ultrasound Radiofrequency Data

  2011cites this paper
• 18F-fluoroethylcholine uptake in arterial vessel walls and cardio vascular risk factors

  2010influential citation
• Lipoprotein-associated phospholipase A2 as a predictive biomarker of sub-clinical inflammation in cardiovascular diseases.

  2010cites this paper
• The Vulnerable Atherosclerotic Plaque: Scope of the Literature

  2010cites this paper
• Exploring newer cardioprotective strategies: ω-3 fatty acids in perspective

  2010influential citation
• Novel systemic cardiovascular disease biomarkers.

  2010cites this paper
• Number 3 Vulnerable Atherosclerotic Plaque

  2010cites this paper
• Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis.

  2010cites this paper
• Fluorescence lifetime imaging microscopy for the characterization of atherosclerotic plaques

  2009cites this paper
• Lipoprotein-Associated Phospholipase A2: An Independent Predictor of Cardiovascular Risk and a Novel Target for Immunomodulation Therapy

  2009cites this paper
• 18F-FDG PET/CT Identifies Patients at Risk for Future Vascular Events in an Otherwise Asymptomatic Cohort with Neoplastic Disease

  2009cites this paper
• Vascular dysfunction measured by fingertip thermal monitoring is associated with the extent of myocardial perfusion defect

  2009cites this paper
• The effect of marine n-3 fatty acids in different doses on plasma concentrations of Lp-PLA2 in healthy adults

  2009influential citation
• Vascular repair mechanisms : Experimental, physiological and clinical studies.

  2009cites this paper
• The vulnerable patient: Refocusing on the plaque?

  2009cites this paper
• Non-invasive assessment of shear strain in the carotid arterial wall based on ultrasound radiofrequency data

  2009cites this paper
• Role of osteo-progenitors in the pathogenesis of vascular calcification

  2009cites this paper
• Shear strain in the adventitial layer of the arterial wall facilitates development of vulnerable plaques

  2009cites this paper
• Lipoprotein-associated phospholipase A2 (Lp-PLA2) Impact and role as cardiovascular risk marker

  2008cites this paper
• Lipoprotein-associated phospholipase A2 (Lp-PLA2)

  2008cites this paper
• Appendix Table 1. References of Primary Studies and Narrative Review Articles

  year unknowncites this paper